{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:58:38Z","timestamp":1779119918150,"version":"3.51.4"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00646","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T15:35:16Z","timestamp":1553873716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization"],"prefix":"10.3389","volume":"10","author":[{"given":"Yoshita","family":"Bhide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inta","family":"Gribonika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00eblle","family":"Voshart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tjarko","family":"Meijerhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"de Vries-Idema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Norley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Guilfoyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Skeldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Othmar G.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Huckriede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2014.00285","article-title":"Universal immunity to influenza must outwit immune evasion","volume":"5","author":"Qui\u00f1ones-Parra","year":"2014","journal-title":"Front Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1128\/CVI.00251-13","article-title":"Protective immunity to lethal influenza infections","volume":"14","author":"Keating","year":"2014"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1099\/vir.0.020784-0","article-title":"Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A\/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice","volume":"91","author":"Bodewes","year":"2010","journal-title":"J Gen Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-0970-4","article-title":"A case report of avian influenza H7N9 killing a young doctor in Shanghai, China","volume":"15","author":"Pan","year":"2015","journal-title":"BMC Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep07632","article-title":"Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jinf.2015.06.009","article-title":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings","volume":"72","author":"Pan","year":"2016","journal-title":"J Infect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1000138","DOI":"10.1371\/journal.ppat.1000138","article-title":"Superior immunogenicity of inactivated whole virus h5n1 influenza vaccine is primarily controlled by toll-like receptor signalling","volume":"4","author":"Geeraedts","year":"2008","journal-title":"PLoS Pathog."},{"key":"B8","first-page":"213","article-title":"Comparison of adverse reactions to whole-virion and split-virion influenza vaccines in hospital personnel","volume":"145","author":"Al-Mazrou","year":"1991","journal-title":"Cmaj."},{"key":"B9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1750-2659.2008.00038.x","article-title":"Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs","volume":"2","author":"Geeraedts","year":"2008","journal-title":"Influenza Other Respi Viruses."},{"key":"B10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-3083.2005.01633.x","article-title":"Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB\/c mice","volume":"62","author":"Hovden","year":"2005","journal-title":"Scand J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/archpedi.1983.02140330006003","article-title":"Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults","volume":"137","author":"Bernstein","year":"1983","journal-title":"Am J Dis Child."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/S0140-6736(03)15014-3","article-title":"Safety and antigenicity of whole virus and subunit influenza A\/Hong Kong\/1073\/99 (H9N2) vaccine in healthy adults: phase I randomised trial","volume":"362","author":"Stephenson","year":"2003","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/icb.2011.70","article-title":"Return of inactivated whole-virus vaccine for superior efficacy","volume":"90","author":"Furuya","year":"2012","journal-title":"Immunol Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1128\/JVI.01615-07","article-title":"Induction of heterosubtypic immunity to influenza virus by intranasal immunization","volume":"82","author":"Quan","year":"2008","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e63163","DOI":"10.1371\/journal.pone.0063163","article-title":"Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine","volume":"8","author":"Budimir","year":"2013","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/irv.12142","article-title":"Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration","volume":"7","author":"Budimir","year":"2013","journal-title":"Influenza Other Respi Viruses."},{"key":"B17","doi-asserted-by":"publisher","first-page":"15ra5","DOI":"10.1126\/scitranslmed.3000624","article-title":"Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus","volume":"2","author":"Khurana","year":"2010","journal-title":"Sci Transl Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody- mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2012","journal-title":"Sci Transl Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1016\/j.vaccine.2015.06.047","article-title":"ISCOMATRIXTM adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans","volume":"33","author":"Chung","year":"2015","journal-title":"Vaccine."},{"key":"B20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/21645515.2017.1415684","article-title":"Adjuvanted in fl uenza vaccines","volume":"14","author":"Tregoning","year":"2018","journal-title":"Hum Vaccin Immunother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e3116","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements","volume":"3","author":"Agger","year":"2008","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e22891","DOI":"10.1371\/journal.pone.0022891","article-title":"CAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferrets","volume":"6","author":"Martel","year":"2011","journal-title":"PLoS ONE."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.vaccine.2017.02.020","article-title":"The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge","volume":"35","author":"Pal","year":"2017","journal-title":"Vaccine."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1016\/j.vaccine.2014.05.050","article-title":"Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant","volume":"32","author":"Korsholm","year":"2014","journal-title":"Vaccine."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/mi.2017.14","article-title":"M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection","volume":"11","author":"Eliasson","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1016\/j.vaccine.2011.03.090","article-title":"A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus","volume":"29","author":"Eliasson","year":"2011","journal-title":"Vaccine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jri.2009.04.002","article-title":"CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa","volume":"81","author":"Cunningham","year":"2009","journal-title":"J Reprod Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1099\/vir.0.2008\/005470-0","article-title":"CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization","volume":"89","author":"Sundling","year":"2008","journal-title":"J Gen Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"Eliasson","year":"2008","journal-title":"Vaccine."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1016\/j.vaccine.2011.06.040","article-title":"Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes","volume":"29","author":"Rosenkrands","year":"2011","journal-title":"Vaccine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model1","volume":"198","author":"Hansen","year":"2008","journal-title":"J Infect Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1371\/journal.pone.0006950","article-title":"A novel liposome-based adjuvant CAF01 for induction of CD8+ cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice","volume":"4","author":"Gram","year":"2009","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1016\/j.vaccine.2011.07.025","article-title":"Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01","volume":"29","author":"Fomsgaard","year":"2011","journal-title":"Vaccine."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0100879","article-title":"Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01","volume":"9","author":"Dietrich","year":"2014","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1600965","DOI":"10.4049\/jimmunol.1600965","article-title":"Low antigen dose in adjuvant-based vaccination selectively induces CD4 T cells with enhanced functional avidity and protective efficacy","volume":"98","author":"Billeskov","year":"2017","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41541-017-0011-y","article-title":"Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection","volume":"2","author":"Espinosa","year":"2017","journal-title":"NPJ Vaccines."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1016\/j.vaccine.2017.08.057","article-title":"Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in G\u00f6ttingen minipigs","volume":"35","author":"Overgaard","year":"2017","journal-title":"Vaccine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/eji.201344358","article-title":"High-frequency vaccine-induced CD8 + T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection","volume":"44","author":"Lindenstr\u00f8m","year":"2014","journal-title":"Eur J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coph.2018.03.015","article-title":"ADP-ribosylating enterotoxins as vaccine adjuvants","volume":"41","author":"Lycke","year":"2018","journal-title":"Curr Opin Pharmacol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J Biol Stand."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00898","article-title":"Induction of cytotoxic T-lymphocyte responses upon subcutaneous administration of a subunit vaccine adjuvanted with an emulsion containing the toll-like receptor 3 ligand poly(I: C)","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1016\/j.vaccine.2011.04.029","article-title":"Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization","volume":"29","author":"Audouy","year":"2011","journal-title":"Vaccine."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e52135","DOI":"10.1371\/journal.pone.0052135","article-title":"Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e30898","DOI":"10.1371\/journal.pone.0030898","article-title":"Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity","volume":"7","author":"Budimir","year":"2012","journal-title":"PLoS ONE."},{"key":"B46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/biostatistics\/kxt024","article-title":"Mixture models for single-cell assays with applications to vaccine studies","volume":"15","author":"Finak","year":"2014","journal-title":"Biostatistics."},{"key":"B47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4049\/jimmunol.166.1.226","article-title":"IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection","volume":"166","author":"Arulanandam","year":"2001","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1461-5347(99)00194-7","article-title":"Intranasal immunization with inactivated influenza vaccine","volume":"2","author":"Potter","year":"1999","journal-title":"Pharm Sci Technolo Today."},{"key":"B49","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.1016\/j.vaccine.2007.10.035","article-title":"Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB\/c mice","volume":"25","author":"Amorij","year":"2007","journal-title":"Vaccine."},{"key":"B50","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/10717544.2018.1435748","article-title":"Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus","volume":"25","author":"Bhide","year":"2018","journal-title":"Drug Deliv."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00714-17","article-title":"In vivo imaging of influenza virus infection in immunized mice","volume":"8","author":"Czak\u00f3","year":"2017","journal-title":"MBio."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.1128\/JVI.03520-12","article-title":"Replication and immunogenicity of swine, equine, and avian H3 subtype influenza viruses in mice and ferrets","volume":"87","author":"Baz","year":"2013","journal-title":"J Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/nm.4224","article-title":"Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination","volume":"22","author":"Lee","year":"2016","journal-title":"Nat Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.immuni.2017.12.009","article-title":"Memory B cells that cross-react with group 1 and group 2 influenza a viruses are abundant in adult human repertoires","volume":"48","author":"McCarthy","year":"2018","journal-title":"Immunity."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep37341","article-title":"Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2017.1290018","article-title":"Fc or not Fc; that is the question : antibody Fc-receptor interactions are key to universal influenza vaccine design","volume":"13","author":"Jegaskanda","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B59","doi-asserted-by":"publisher","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B60","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","article-title":"Tackling influenza with broadly neutralizing antibodies","volume":"24","author":"Corti","year":"2017","journal-title":"Curr Opin Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1016\/j.vaccine.2010.05.019","article-title":"Studies on the usefulness of intranasal inactivated influenza vaccines","volume":"28","author":"Tamura","year":"2010","journal-title":"Vaccine."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0085582","article-title":"Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity","volume":"9","author":"Muramatsu","year":"2014","journal-title":"PLoS ONE."},{"key":"B63","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.celrep.2018.03.027","article-title":"Glycosylation of human IgA directly inhibits influenza A and other sialic-acid-binding viruses","volume":"23","author":"Maurer","year":"2018","journal-title":"Cell Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1046\/j.0019-2805.2001.01368.x","article-title":"Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus","volume":"105","author":"Zhang","year":"2002","journal-title":"Immunology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","article-title":"Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines","volume":"168","author":"Asahi","year":"2002","journal-title":"J Immunol."},{"key":"B66","first-page":"37","article-title":"The B-cell targeted CTA1-DD vaccine adjuvant is highly effective at enhancing antibody as well as CTL responses","volume":"3","author":"Lycke","year":"2001","journal-title":"Curr Opin Mol Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s41385-018-0017-4","article-title":"IL-1\u03b2 as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses","volume":"11","author":"Lapuente","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue\u2013resident memory T cells provide heterosubtypic protection to influenza infection","volume":"1","author":"Zens","year":"2016","journal-title":"JCI Insight."},{"key":"B69","doi-asserted-by":"publisher","first-page":"16379","DOI":"10.1038\/s41598-017-16419-w","article-title":"Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs","volume":"7","author":"Ricklin","year":"2017","journal-title":"Sci Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1128\/JVI.00150-11","article-title":"Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance","volume":"85","author":"LaMere","year":"2011","journal-title":"J Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1099\/jgv.0.000518","article-title":"Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection","volume":"97","author":"Fujimoto","year":"2016","journal-title":"J Gen Virol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbiotec.2018.08.022","article-title":"Monophosphoryl lipid a-adjuvanted virosomes with Ni-chelating lipids for attachment of conserved viral proteins as cross-protective influenza vaccine","volume":"1700645","author":"Dong","year":"2018","journal-title":"Biotechnol J."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T15:35:20Z","timestamp":1553873720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2019.00646"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00646","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]},"article-number":"646"}}